In the European Union (EU), the drug Lynparza (olaparib), developed by AstraZeneca and MSD, has been approved for the adjuvant treatment of adult patients with germline BRCA1/2 mutations (gBRCAm) who….
The Ministry of Health and Family Welfare needs to create a distinct department for the medical device industry. Sunil Khurana, CEO and managing director of BPL Medical Technologies, explains that….
Ayushman Bharat Yojana, a health insurance programme, has been suspended at the PGI for patients from the state after the Punjab Government failed to pay seven months’ worth of dues….
Amgen will pay $4 billion to acquire ChemoCentryx, adding a recently approved medicine for an autoimmune condition. Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology business….
Adar Poonawalla, CEO of Serum Institute of India, stated on Tuesday that his company is researching a monkeypox vaccine as instances in the nation are on the rise. During a….
Israel Makov, the chairman of Sun Pharma, will leave the organisation following the annual general meeting on August 29, the firm said on Wednesday. Makov will resign because his term….
